Human jejunal permeability of cyclosporin A: influence of surfactants on P-glycoprotein efflux in Caco-2 cells.

Abstract:

PURPOSE:The purpose of this work was to determine the jejunal permeability of cyclosporin A (CsA) in humans and whether formulation variables modulate the effects of P-glycoprotein (P-gp) on the permeability of CsA in Caco-2 cells. METHODS:A solution containing CsA, phenylalanine, propranolol, polyethyleneglycol (PEG) 400, and PEG 4000 was perfused through a 10-cm jejunal segment in 12 subjects. Caco-2 transport studies were performed using previously reported methodology. RESULTS:The mean Peff (+/- SD) of CsA in humans was 1.65 (0.53). The mean permeabilities for phenylalanine, propranolol, and PEG 400 were 4.54 (2.39), 2.90 (1.28), and 0.83 (0.51) x 10(-4) cm/s, respectively. The presence of surfactants significantly decreased the permeabilities of CsA in both directions in Caco-2 cells. CONCLUSIONS:The results suggest that the effects of surfactants via micellar solubilization and inhibition of P-gp efflux on CsA transport in Caco-2 cells are significant. CsA can rightly be classified as a low solubility-high permeability Class II BCS drug and its highly variable absorption from Sandimmune oral formulations is the result of poor dissolution characteristics.

journal_name

Pharm Res

journal_title

Pharmaceutical research

authors

Chiu YY,Higaki K,Neudeck BL,Barnett JL,Welage LS,Amidon GL

doi

10.1023/a:1023481418576

subject

Has Abstract

pub_date

2003-05-01 00:00:00

pages

749-56

issue

5

eissn

0724-8741

issn

1573-904X

journal_volume

20

pub_type

杂志文章
  • Dependence of dissolution rate on surface area: is a simple linear relationship valid for co-compressed drug mixtures?

    abstract::A quantitative analysis of the dependence of dissolution rate on the relative surface area occupied by two non-interacting drug mixtures from co-compressed slabs is described. The results from the experimental dissolution rates of each component from naproxen/phenytoin co-compressed slabs under laminar flow conditions...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1023/a:1018979419714

    authors: Neervannan S,Southard MZ,Stella VJ

    更新日期:1994-10-01 00:00:00

  • Development of Vancomycin Dose Individualization Strategy by Bayesian Prediction in Patients Receiving Continuous Renal Replacement Therapy.

    abstract:PURPOSE:Vancomycin (VCM) concentration is often out of therapeutic range (10-20 μg/ml) in patients receiving continuous renal replacement therapy (CRRT). The purposes of this study were to develop a practical VCM population pharmacokinetic (PPK) model and to evaluate the potential of Bayesian prediction-based therapeut...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1007/s11095-020-02820-0

    authors: Oda K,Jono H,Kamohara H,Nishi K,Tanoue N,Saito H

    更新日期:2020-05-28 00:00:00

  • The effect of conformation on membrane permeability of an acyloxyalkoxy-linked cyclic prodrug of a model hexapeptide.

    abstract:PURPOSE:To determine the different conformations of the acyloxyalkoxy-linked cyclic prodrug 1 of the model hexapeptide 2 in solution and to investigate the relationship between these solution conformations and the cellular permeability characteristics of this prodrug. METHODS:Two-dimensional Homonuclear Hartmann-Hahn ...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1023/a:1016484522113

    authors: Gangwar S,Jois SD,Siahaan TJ,Vander Velde DG,Stella VJ,Borchardt RT

    更新日期:1996-11-01 00:00:00

  • Cationic lipid-based gene delivery systems: pharmaceutical perspectives.

    abstract::Gene delivery systems are designed to control the location of administered therapeutic genes within a patient's body. Successful in vivo gene transfer may require (i) the condensation of plasmid and its protection from nuclease degradation, (ii) cellular interaction and internalization of condensed plasmid, (iii) esca...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章,评审

    doi:10.1023/a:1012187414126

    authors: Mahato RI,Rolland A,Tomlinson E

    更新日期:1997-07-01 00:00:00

  • Characterization of pulmonary alveolar esterases of the primate Cercopithecus pygerythrus.

    abstract:PURPOSE:To evaluate and classify the hydrolases of the primate lung. METHODS:Homologous series of aromatic, aliphatic, and choline ester substrates were assayed with the pH-stat method to obtain the Michaelis-Menten kinetic constants, Vmax and K(m), for the enzymes in pulmonary alveolar tissue with esterase activity. ...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1023/a:1012004911942

    authors: Leng HM,Syce JA

    更新日期:1997-02-01 00:00:00

  • Receptor-mediated magnetic carriers: basis for targeting.

    abstract::A new magnetic microsphere carrier has been formulated that may localize drugs by both biochemical and physical means. The microspheres, prepared from the polysaccharide chitosan, are designed to bind to anionic glycosaminoglycan receptors on the surface of capillary endothelial cells. The microspheres were formulated...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1023/a:1015978704810

    authors: Gallo JM,Hassan EE

    更新日期:1988-05-01 00:00:00

  • A Novel Monocarboxylate Transporter Inhibitor as a Potential Treatment Strategy for γ-Hydroxybutyric Acid Overdose.

    abstract:PURPOSE:Monocarboxylate transporter (MCT) inhibition represents a potential treatment strategy for γ-hydroxybutyric acid (GHB) overdose by blocking its renal reabsorption in the kidney. This study further evaluated the effects of a novel, highly potent MCT inhibitor, AR-C155858, on GHB toxicokinetics/toxicodynamics (TK...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1007/s11095-014-1583-0

    authors: Vijay N,Morse BL,Morris ME

    更新日期:2015-06-01 00:00:00

  • Mesoporous Silica Nanoparticle-Coated Microneedle Arrays for Intradermal Antigen Delivery.

    abstract:PURPOSE:To develop a new intradermal antigen delivery system by coating microneedle arrays with lipid bilayer-coated, antigen-loaded mesoporous silica nanoparticles (LB-MSN-OVA). METHODS:Synthesis of MSNs with 10-nm pores was performed and the nanoparticles were loaded with the model antigen ovalbumin (OVA), and coate...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1007/s11095-017-2177-4

    authors: Tu J,Du G,Reza Nejadnik M,Mönkäre J,van der Maaden K,Bomans PHH,Sommerdijk NAJM,Slütter B,Jiskoot W,Bouwstra JA,Kros A

    更新日期:2017-08-01 00:00:00

  • Formulating paclitaxel in nanoparticles alters its disposition.

    abstract:PURPOSE:Paclitaxel is active and widely used to treat multiple types of solid tumors. The commercially available paclitaxel formulation uses Cremophor/ethanol (C/E) as the solubilizers. Other formulations including nanoparticles have been introduced. This study evaluated the effects of nanoparticle formulation of pacli...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1007/s11095-005-4581-4

    authors: Yeh TK,Lu Z,Wientjes MG,Au JL

    更新日期:2005-06-01 00:00:00

  • In vitro lipolysis and intestinal transport of β-arteether-loaded lipid-based drug delivery systems.

    abstract:PURPOSE:We aimed to assess the fate of β-arteether lipid-based drug delivery systems (AE-LBDDS) in terms of resistance to lipolysis and permeation across intestinal cells. METHODS:AE-LBDDS contained Tween 80 or Cremophor EL as surfactants, ethanol, Maisine 35-1 and vegetable oil. The solubilization behavior of AE was ...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1007/s11095-013-1094-4

    authors: Memvanga PB,Eloy P,Gaigneaux EM,Préat V

    更新日期:2013-10-01 00:00:00

  • Inhibition of tumor angiogenesis by tumstatin: insights into signaling mechanisms and implications in cancer regression.

    abstract::Growing tumors develop additional new blood vessels to meet the demand for adequate nutrients and oxygen, a process called angiogenesis. Cancer is a highly complex disease promoted by excess angiogenesis; interfering with this process poses for an attractive approach for controlling tumor growth. This hypothesis led t...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章,评审

    doi:10.1007/s11095-008-9634-z

    authors: Sudhakar A,Boosani CS

    更新日期:2008-12-01 00:00:00

  • Epidermal iontophoresis: I. Development of the ionic mobility-pore model.

    abstract:PURPOSE:An integrated ionic mobility-pore model for epidermal iontophoresis is developed from theoretical considerations using both the free volume and pore restriction forms of the model for a range of solute radii (rj) approaching the pore radii (rp) as well as approximation of the pore restriction form for rj/rp < 0...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1023/a:1011907201096

    authors: Roberts MS,Lai PM,Anissimov YG

    更新日期:1998-10-01 00:00:00

  • Sustainable Dissolution Performance of a Carrier Tailored Electrospun.

    abstract:PURPOSE:This study aims to conduct an impact investigation in the hydrophobic-hydrophilic balance as an important factor for dissolution improvement of a hydrophilic carrier-based solid dispersion system. METHODS:Polymeric carriers with different hydrophobic to hydrophilic ratios were used to prepare several electrosp...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1007/s11095-019-2734-0

    authors: Teoh XY,Yeoh Y,Yoong LK,Chan SY

    更新日期:2020-01-07 00:00:00

  • Influence of the Size of Cohorts in Adaptive Design for Nonlinear Mixed Effects Models: An Evaluation by Simulation for a Pharmacokinetic and Pharmacodynamic Model for a Biomarker in Oncology.

    abstract:PURPOSE:In this study we aimed to evaluate adaptive designs (ADs) by clinical trial simulation for a pharmacokinetic-pharmacodynamic model in oncology and to compare them with one-stage designs, i.e., when no adaptation is performed, using wrong prior parameters. METHODS:We evaluated two one-stage designs, ξ0 and ξ*, ...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1007/s11095-015-1693-3

    authors: Lestini G,Dumont C,Mentré F

    更新日期:2015-10-01 00:00:00

  • Physiologically based pharmacokinetic model for composite nanodevices: effect of charge and size on in vivo disposition.

    abstract:PURPOSE:To characterize temporal exposure and elimination of 5 gold/dendrimer composite nanodevices (CNDs) (5 nm positive, negative, and neutral, 11 nm negative, 22 nm positive) in mice using a physiologically based mathematical model. METHODS:400 ug of CNDs is injected intravenously to mice bearing melanoma cell line...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1007/s11095-012-0784-7

    authors: Mager DE,Mody V,Xu C,Forrest A,Lesniak WG,Nigavekar SS,Kariapper MT,Minc L,Khan MK,Balogh LP

    更新日期:2012-09-01 00:00:00

  • Comparison of CYP2D6 content and metoprolol oxidation between microsomes isolated from human livers and small intestines.

    abstract:PURPOSE:To assess the role of intestinal CYP2D6 in oral first-pass drug clearance by comparing the enzyme content and catalytic activity of a prototype CYP2D6 substrate, metoprolol, between microsomes prepared from human intestinal mucosa and from human livers. METHODS:Microsomes were prepared from a panel of 31 human...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1023/a:1018989211864

    authors: Madani S,Paine MF,Lewis L,Thummel KE,Shen DD

    更新日期:1999-08-01 00:00:00

  • Experimental design and efficient parameter estimation in preclinical pharmacokinetic studies.

    abstract::Monte Carlo simulation technique used to evaluate the effect of the arrangement of concentrations on the efficiency of estimation of population pharmacokinetic parameters in the preclinical setting is described. Although the simulations were restricted to the one compartment model with intravenous bolus input, they pr...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1023/a:1016267811074

    authors: Ette EI,Howie CA,Kelman AW,Whiting B

    更新日期:1995-05-01 00:00:00

  • Liposomes co-Loaded with 6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3 (PFKFB3) shRNA Plasmid and Docetaxel for the Treatment of non-small Cell Lung Cancer.

    abstract:PURPOSE:Non-small cell lung cancer is the leading cause of cancer related deaths globally. Considering the side effects and diminishing chemosensitivity to chemotherapy, novel treatment approaches are sought. Hence, we aim to develop a liposomal co-delivery system of pDNA expressing shRNA against PFKFB3 (pshPFKFB3) and...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1007/s11095-017-2244-x

    authors: Chowdhury N,Vhora I,Patel K,Doddapaneni R,Mondal A,Singh M

    更新日期:2017-11-01 00:00:00

  • An organic acid-induced sigmoidal release system for oral controlled-release preparations.

    abstract::To achieve time-controlled or site-specific drug delivery in the gastrointestinal tract, a sigmoidal release system (SRS) was developed, which achieved a prolonged lag time, followed by rapid release. The theophylline beads with a thick Eudragit RS film coating showed very low drug release in water, whereas the releas...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1023/a:1018910114436

    authors: Narisawa S,Nagata M,Danyoshi C,Yoshino H,Murata K,Hirakawa Y,Noda K

    更新日期:1994-01-01 00:00:00

  • Pharmacokinetics of once-a-month injectable microspheres of leuprolide acetate.

    abstract::The pharmacokinetic parameters of leuprolide acetate, a potent analogue of LH-RH, were determined in rats and dogs after i.v. and s.c. dosing with leuprolide solution. The effective human dose of once-a-month injectable microspheres of leuprolide was estimated to be about 3.2 to 8.1 mg analogue/month using these param...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1023/a:1015818504906

    authors: Okada H,Inoue Y,Heya T,Ueno H,Ogawa Y,Toguchi H

    更新日期:1991-06-01 00:00:00

  • Coupling of aggregation and immunogenicity in biotherapeutics: T- and B-cell immune epitopes may contain aggregation-prone regions.

    abstract::Biotherapeutics, including recombinant or plasma-derived human proteins and antibody-based molecules, have emerged as an important class of pharmaceuticals. Aggregation and immunogenicity are among the major bottlenecks during discovery and development of biotherapeutics. Computational tools that can predict aggregati...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1007/s11095-011-0414-9

    authors: Kumar S,Singh SK,Wang X,Rup B,Gill D

    更新日期:2011-05-01 00:00:00

  • Dual-Targeted Delivery of Nanoparticles Encapsulating Paclitaxel and Everolimus: a Novel Strategy to Overcome Breast Cancer Receptor Heterogeneity.

    abstract:PURPOSE:The intratumoral heterogeneity observed in breast cancer (BC), in particular with regard to cell surface receptor expression, can hinder the success of many targeted cancer therapies. The development of novel therapeutic agents that target more than one receptor can overcome this inherent property of tumors and...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1007/s11095-019-2684-6

    authors: Houdaihed L,Evans JC,Allen C

    更新日期:2020-01-21 00:00:00

  • Nebulization of fluids of different physicochemical properties with air-jet and ultrasonic nebulizers.

    abstract:PURPOSE:Empirical formulae relate the mean size of primary droplets from jet and ultrasonic nebulizers to a fluid's physicochemical properties. Although the size selective "filtering" effects of baffling and evaporation may modify the secondary aerosol produced, this research sought to evaluate whether viscosity and su...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1023/a:1016205520044

    authors: McCallion ON,Taylor KM,Thomas M,Taylor AJ

    更新日期:1995-11-01 00:00:00

  • Saturable processes affecting renal clearance of cefixime in dogs.

    abstract::The pharmacokinetics of cefixime, a new orally active cephalosporin, was studied after an intravenous dose of 50 mg/kg to four beagle dogs. Cefixime was shown to exhibit concentration dependent serum protein binding and saturable tubular reabsorption. The drug was excreted mainly in the urine, the net result of glomer...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1023/A:1016309923717

    authors: Tonelli AP,Bialer M,Look ZM,Carson S,Yacobi A

    更新日期:1986-06-01 00:00:00

  • Tolerability and absorption enhancement of intranasally administered octreotide by sodium taurodihydrofusidate in healthy subjects.

    abstract::Nasal sprays containing different concentrations of the somatostatin analogue octreotide and sodium tauro-24,25-dihydrofusidate (STDHF) as an absorption promoter were evaluated in two consecutive pharmacokinetic studies in healthy volunteers to characterize their bioavailability and local tolerability. The concentrati...

    journal_title:Pharmaceutical research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1023/a:1018927710280

    authors: Kissel T,Drewe J,Bantle S,Rummelt A,Beglinger C

    更新日期:1992-01-01 00:00:00

  • Nanomechanical properties of selected single pharmaceutical crystals as a predictor of their bulk behaviour.

    abstract:PURPOSE:The main goal of this research was to assess the mechanical properties of APIs' polymorphic forms at the single-crystal level (piroxicam, famotidine, nifedipine, olanzapine) in order to predict their bulk deformational attributes, which are critical for some pharmaceutical technology processes. METHODS:The mec...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1007/s11095-014-1475-3

    authors: Egart M,Janković B,Lah N,Ilić I,Srčič S

    更新日期:2015-02-01 00:00:00

  • High Content Solid Dispersions for Dose Window Extension: A Basis for Design Flexibility in Fused Deposition Modelling.

    abstract:PURPOSE:This study uses high drug content solid dispersions for dose window extension beyond current demonstrations using fused deposition modelling (FDM) to; i) accommodate pharmaceutically relevant doses of drugs of varying potencies at acceptable dosage form sizes and ii) enable enhanced dose flexibility via modular...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1007/s11095-019-2720-6

    authors: Govender R,Abrahmsén-Alami S,Folestad S,Larsson A

    更新日期:2019-12-17 00:00:00

  • Release of plasmid DNA-encoding IL-10 from PLGA microparticles facilitates long-term reversal of neuropathic pain following a single intrathecal administration.

    abstract:PURPOSE:Interleukin-10 (IL-10) is an anti-inflammatory molecule that has achieved interest as a therapeutic for neuropathic pain. In this work, the potential of plasmid DNA-encoding IL-10 (pDNA-IL-10) slowly released from biodegradable microparticles to provide long-term pain relief in an animal model of neuropathic pa...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1007/s11095-010-0077-y

    authors: Soderquist RG,Sloane EM,Loram LC,Harrison JA,Dengler EC,Johnson SM,Amer LD,Young CS,Lewis MT,Poole S,Frank MG,Watkins LR,Milligan ED,Mahoney MJ

    更新日期:2010-05-01 00:00:00

  • Solid-state stability testing of drugs by isothermal calorimetry.

    abstract::A new technique has been developed to calculate rapidly the solid-state room-temperature degradation rate of drugs and drug candidates. The technique utilizes measurements of the initial rate of heat output at several elevated temperatures by isothermal calorimetry and the degradation rate of the compound determined a...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1023/a:1015865319250

    authors: Koenigbauer MJ,Brooks SH,Rullo G,Couch RA

    更新日期:1992-07-01 00:00:00

  • P-Glycoprotein attenuates brain uptake of substrates after nasal instillation.

    abstract:PURPOSE:Previous literature has suggested the absence of an effective barrier between the nasal mucosa and the brain for compounds administered via the nasal route. These experiments were conducted to elucidate the role of the blood-brain barrier efflux transporter P-glycoprotein (P-gp) in attenuating delivery of P-gp ...

    journal_title:Pharmaceutical research

    pub_type: 杂志文章

    doi:10.1023/a:1025053115583

    authors: Graff CL,Pollack GM

    更新日期:2003-08-01 00:00:00